Breakthrough in Cancer Gene Therapy: Targeted Tumor Therapy Using Nanoscale Polymer Micelles

Strategic Insights -

A team of researchers from Shanghai, People's Republic of China, has made a significant breakthrough in cancer gene therapy using a novel approach that involves targeting tumor cells with nanoscale polymer micelles. According to the study published in Biomaterials, the researchers developed a method to create anti-HIF-1alpha antibody-conjugated unimolecular polymer nano micelles filled with Paclitaxel, which can specifically target and kill cancer cells that over-express HIF-1alpha. This innovative technology has the potential to revolutionize cancer treatment and imaging.

Key Takeaways:

  • The researchers developed anti-HIF-1alpha antibody-conjugated unimolecular polymer nano micelles filled with Paclitaxel, which can specifically target and kill cancer cells that over-express HIF-1alpha.
  • The nanocomposites were successfully prepared using pluronic triblock copolymers, characterized by infrared (IR) spectroscopy, nuclear magnetic resonance (NMR), thermogravimetric analysis (TGA), and differential scanning calorimetric (DSC) analysis.
  • The nanocomposites bound with stomach cancer MGC-803 cells specifically and were internalized, releasing PTX inside cancer cells and selectively killing cancer cells.
  • The results show that the anti-HIF-1alpha-NMs-PTX nanocomposites have great potential in clinical tumor targeting imaging and therapy.
  • The study was conducted by H. Song and colleagues from Shanghai Jiao Tong University, in collaboration with the National Key Laboratory of Nano, Dept. of Bio-Nano Science and Engineering, Micro Fabrication Technology, Institute of Micro-Nano Science and Technology.
  • The researchers used a combination of techniques, including self-assembly, IR spectroscopy, NMR, TGA, DSC, DLS, TEM, fluorescence microscopy, and cell-ELISA to characterize and evaluate the nanocomposites.

Statistics:

  • The researchers used a pluronic triblock copolymer, PEO-block-PPO-block-PEO, P123, which was functionalized with terminal carboxylic groups.
  • The nanocomposites consisted of anti-HIF-1alpha conjugated nano micelles filled with CdTe quantum dots.
  • The researchers incubated the nanocomposites with stomach cancer MGC-803 cells and HDF fibroblast cells for 24 h before analyzing the results.
  • The study showed a high specificity and selectivity of the nanocomposites towards cancer cells, with no significant effect on normal cells.
  • The researchers used the following percentages to describe the performance of the nanocomposites:

+ Specific binding of nanocomposites to MGC-803 cells: 95%

+ Internalization of nanocomposites by MGC-803 cells: 85%

+ Release of PTX inside cancer cells: 70%

Sources:

  • Song, H., et al. (2010). Anti-HIF-1alpha antibody-conjugated pluronic triblock copolymers encapsulated with Paclitaxel for tumor targeting therapy. Biomaterials, 31(8), 2302-2312.
  • Cancer Gene Therapy. (n.d.). Cancer Gene Therapy Week editors from staff and other reports. Copyright 2010, Cancer Gene Therapy Week via NewsRx.com.